NCT07545486 2026-04-22
ATOM-1st
Chirec
Not yet recruiting
Clinical Trials
8 trialsNCT05522491 2025-12-11
Olaparib in the Treatment of BRCA1/2 Unmutated and BRCA1 Promoter Methylated Recurrent and Metastatic Triple-negative Breast Cancer
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT07245901 2025-11-24
Safety and Tolerability of a mRNA Vaccine Encoding Tumor-Specific Circular RNA Antigens in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1/2 Not yet recruiting
NCT06895681 2025-11-10
UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations
University of California, San Francisco
Not yet recruiting
NCT06719856 2024-12-27
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06720298 2024-12-27
CD147 Targeting Peptide Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Not yet recruiting
NCT06541301 2024-11-19
PICCHEST
European Institute of Oncology
Phase NA Not yet recruiting
NCT06537505 2024-08-05
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
Beidahuang Industry Group General Hospital
Phase 2 Not yet recruiting